American Association of Clinical Endocrinologists (AACE)

The Synthroid brand of levothyroxine improved thyroid-stimulating hormone (TSH) levels by a significantly greater margin compared with generic versions of the synthetic T4 (LT4) hormones for patients with hypothyroidism.

At AACE 2017, John Bilezikian, MD, discussed the latest FDA approval of Tymlos for postmenopausal women with osteoporosis and for women who are at high risk for fracture.

According to Kathleen “Kittie” Wyne, MD, PhD, The Ohio State University, in the identification and treatment of hypothyroidism, people need to be aware that the symptoms associated with hypothyroidism can be non-specific.

At AACE 2017, Kathleen “Kittie” Wyne, MD, PhD, The Ohio State University, discussed new data on hypothyroidism. Although hypothyroidism requires lifelong adherence to therapy, compliance still remains challenging.

More than 25% of the US population over the age of 65 has diabetes.

At AACE 2017, Jagdeesh Ullal, MD, MS, Eastern Virginia Medical School discussed data from his team’s study that assessed the efficacy of an electronic glycemic management system (eGlycemic Management) management in controlling blood sugars in the hospital setting.

“Treatment of diabetic foot ulcers depends upon the severity of the infection,” said Andrew Boulton, MD, University of Manchester, UK, University of Miami, Florida at AACE 2017.

According to Andrew Boulton, MD, University of Manchester, UK, University of Miami, Florida, the most important take home message for doctors regarding the diabetic foot and reducing amputations, is to remove their patients’ shoes and socks and look at their feet.

Heart failure is diabetes’ most sinister, most overlooked complication

AACE speakers on the challenge of managing patients’ adrenal conditions

At AACE 2017, Shashank Joshi, MD, Lilavati Hospital and Research Centre, Mumbai explained his team’s simple diabetes treatment formula: A for A1C, B for blood pressure, C for cholesterol (LDL cholesterol), and D for diet that’s culturally sensitive and adaptable.

Shashank Joshi, MD, Lilavati Hospital and Research Centre, Mumbai, spoke to MD Magazine about the cultural considerations when attempting to personalize diabetes care.

Somatropin increased HDL-C levels in patients with GHD at 24 months.

A new category of cardiovascular “extreme risk” has LDL-C goals of

In terms of specific endocrine functions, bones favor glucose metabolism and homeostasis and are necessary for memory formation and for muscle function during exercise. Gerard Karsenty, MD, PhD also explained that osteo-calcium is not only necessary to foster this function, but it’s also sufficient, and can improve this function in animals.

More research and education could to prevent inherent risks

While everyone has the fibroblast 23 hormone there has been some research into whether it can be linked to diseases and other conditions that can make some people sick.

While its base is the same as currently used tests for thyroid cancer a new approach is looking to redefine the specificity and exclusivity to help patients get a better idea of their condition.

Patients being tested for thyroid cancer want to know they are receiving the most accurate information possible following the test. A new method could help provide both answers for patients and direction for doctors about the best course of action.

Treatment for patients who are obese or overweight have seen significant improvements in treatment options over the past decade, but there is still much ore work to be done.

In a global community it can be just as important for doctors to remember where their patients come from as where they are now. Understanding different cultures can help provide care to all segments of the population.

Patients with chronic critical illness face a litany of health issues after their treatment needing care for these conditions. While pamidronate has been used in the past a new study looked at whether the treatment affects areas like bone absorption and overall mortality and ventilator liberation.

A considerable amount of progress has been made in treating diabetes this year both for type 1 and type 2 diabetes. The approval of new medications and potential devices in the future have made for a bright outlook for patients.

Edward Damiano, PhD, Professor of Biomedical Engineering, Boston University shared his 2013-2015 research results surrounding the acclaimed bionic pancreas at the 24th American Association of Clinical Endocrinologists Nashville, TN.

Testosterone Replacement Therapy may be the way to go for some patients, but for others bioidenticals and other medications may provide better treatment over a shorter period of time.

Men may not always want to go to the doctor but for an issue like low testosterone seeking treatment can make a considerable difference in their daily quality of life.

While the research being done in endocrinology using genetics is only done in a few select locations, that work can make a big difference in helping a patient answer some of their most pressing questions.

Sometimes even the most seasoned endocrinologists will encounter a patient who they have trouble finding a diagnosis. There is now an effort to use advances in science to help find answers for some of the field's most troubling questions

For younger male patients with low testosterone traditional treatments may not be the best method for what could be a temporary condition.

When doctors diagnose patients with diabetes they are only at the beginning stages of treatment which will last patients for many years if not the rest of their lives. How they handle that process is just as important as the process itself.